Aneurin Bevan University Health Board is the local health board of NHS Wales for Gwent, in the south-east of Wales. Headquartered in Caerleon, the local health board was launched in October 2009 through the merger of Gwent Healthcare NHS Trust and Blaenau Gwent, Caerphilly, Newport, Torfaen, and Monmouthshire LHBs.

During the past decade, Aneurin bevan University Health Board conducted 19 clinical trials. In the 10-year time frame, 19 clinical trials started and 1 clinical trials were completed, i.e. on average, 5.3% percent of trials that started reached the finish line to date. In the past 5 years, 7 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Aneurin bevan University Health Board" #1 sponsor was "Aneurin Bevan University Health Board" with 2 trials, followed by "Anna Pennington" with 1 trials sponsored, "Belfast Health and Social Care Trust" with 1 trials sponsored, "Clinical Evaluation Research Unit at Kingston General Hospital" with 1 trials sponsored and "Guy's and St Thomas' NHS Foundation Trust" with 1 trials sponsored. Other sponsors include 8 different institutions and companies that sponsored additional 18 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Aneurin bevan University Health Board" #1 collaborator was "Aneurin Bevan University Health Board" with 5 trials as a collaborator, "Cambridge University Hospitals NHS Foundation Trust" with 2 trials as a collaborator, "NHS Lothian" with 2 trials as a collaborator, "National Institute for Health Research, United Kingdom" with 2 trials as a collaborator and "Queen's University, Belfast" with 2 trials as a collaborator. Other collaborators include 52 different institutions and companies that were collaborators in the rest 60 trials.

According to Clinical.Site data, the most researched conditions in "Aneurin bevan University Health Board" are "Critical Illness" (4 trials), "Sepsis" (3 trials), "Stroke" (2 trials), "Venous Ulcer" (2 trials) and "Abdominal Sepsis" (1 trials). Many other conditions were trialed in "Aneurin bevan University Health Board" in a lesser frequency.

Most popular intervention types in "Aneurin bevan University Health Board" are "Drug" (6 trials), "Other" (6 trials), "Procedure" (3 trials), "Behavioral" (1 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Acceptance and Commitment Therapy (ACT)" (1 trials), "Cefuroxime" (1 trials), "Cisplatin" (1 trials), "Cladribine (MAVENCLAD®)" (1 trials) and "Clonidine" (1 trials). Other intervention names were less common.

The vast majority of trials in "Aneurin bevan University Health Board" are 19 trials for "All" genders.

Currently, there are NaN active trials in "Aneurin bevan University Health Board". 1 are not yet recruiting, 6 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in Aneurin bevan University Health Board, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Aneurin bevan University Health Board, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 9 trials that are defined as “Not Applicable".